FEATURED EDITORIAL
The treatment landscape for psoriatic arthritis (PsA) is evolving rapidly, with data presented at EULAR 2025 signaling a new chapter in disease management with the emergence of a selective tyrosine kinase 2 (TYK2) inhibitor.
- New Regulatory Considerations For Animal Testing And The Consequences For Drug Product Formulation Development
- From Undruggable To Druggable: The Science Reshaping Small Molecule Discovery
- Five Takeaways from BIO 2025 and Why You Should Stay Tuned
- From Matrix To Medicine: New Frontiers In Treating Pulmonary Fibrosis And PH
- Tackling Antimicrobial Resistance With Precision Targeting
- Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet
- A Guide To Designing mRNA Medicines
FEATURED APPLICATION CONTENT
-
Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.
-
Discover a company that tripled productivity and cut costs by optimizing its seed train process to achieve major gains without infrastructure expansion.
-
Discover how a top CDMO leveraged dynamic perfusion technology to boost biomanufacturing throughput, cut capital costs, and enable flexible, multi-modality production.
-
Explore cost-saving innovations in purification using a system that achieves consistent product quality and yield while significantly reducing resin use and enhancing large-scale efficiency.
-
Discover how a leading biopharma company boosted flexibility and quadrupled productivity by implementing a concentrated fed-batch process in a single-use facility.
-
Decarbonizing healthcare and pharmaceuticals is vital to meet climate goals and safeguard public health. Learn why these energy-intensive sectors must act swiftly to reduce emissions and navigate complex global supply chains.
-
Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
-
Raman spectroscopy has revolutionized manufacturing through real-time monitoring. Explore a system that enables a seamless calibration model transfer from small- to large-scale bioreactors to enhance scalability and efficiency.
-
Adeno-associated virus is a key gene therapy vector. Explore how digital PCR offers precise, standard-free quantification with improved consistency and inhibitor tolerance over traditional qPCR methods.
-
Digital PCR offers precise, inhibitor-resistant DNA quantification and genome integrity assessment. Discover how this method enhances accuracy and reproducibility, especially in AAV analysis, using multiplexed targets and Poisson-based calculations.
-
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
FEATURED NEWS HEADLINES
- Connect Biopharma's Exclusive Licensee In China, Simcere Pharmaceutical, Announced Submission Of Its New Drug Application For Rademikibart For The Treatment Of Atopic Dermatitis In China
- Collaborative Drug Discovery And deepmirror Announce Collaboration For Humanitarian And Commercial Drug Discovery
- KAIST Presents A Breakthrough In Overcoming Drug Resistance In Cancer – Hope For Treating Intractable Diseases Like Diabetes
- Adagene And ConjugateBio Partner To Develop Novel Antibody Drug Conjugate
- New Drug Targets 'Zombie Cells' In Effort To Prevent Liver Disease, Cancer
- Eluciderm, Inc. Announces U.S. FDA Clearance Of IND Application For ELU42
- Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For ET-600 (Desmopressin Oral Solution)
- Chugai And Gero Enter Into Joint Research And License Agreement To Develop Novel Therapies For Age-Related Diseases
- FF-10832 Granted FDA Orphan Drug Designation For The Treatment Of Biliary Tract Cancer
- Research Opens Up New Avenue For Tuberculosis Drug Discovery
ARCHIVED NEWSLETTER
- 07.10.25 -- Take a look at our useful PUPSIT overview and implementation resources.
- 07.08.25 -- Designing Our Way Toward Circular RNA Medicines With AI
- 07.01.25 -- Will Genome Modifications Define Next-Gen AAV Vectors?
- 06.24.25 -- Protecting Intellectual Property In The Genomics Revolution
- 06.19.25 -- Your helping hand in filtration for high concentration drugs.